3rd Quarter - Report

FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 4679 Stop Corporate Inversions Act of 2014, S 2360 Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity)

LobbyistCovered position, as disclosed
JOEL JOHNSON —

Contacted: SENATE

Bills named: H.R. 4679 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.